Abstract
The folding of both wild-type and mutant forms of the cystic-fibrosis transmembrane-conductance regulator (CFTR), a plasma-membrane chloride-ion channel, is inefficient1,2,3,4. Most nascent CFTR is retained in the endoplasmic reticulum and degraded by the ubiquitin proteasome pathway5,6,7. Aberrant folding and defective trafficking of CFTRΔF508 is the principal cause of cystic fibrosis3,8,9, but how the endoplasmic-reticulum quality-control system targets CFTR for degradation remains unknown. CHIP is a cytosolic U-box protein that interacts with Hsc70 through a set of tetratricorepeat motifs10. The U-box represents a modified form of the ring-finger motif that is found in ubiquitin ligases11 and that defines the E4 family of polyubiquitination factors12,13. Here we show that CHIP functions with Hsc70 to sense the folded state of CFTR and targets aberrant forms for proteasomal degradation by promoting their ubiquitination. The U-box appeared essential for this process because overexpresion of CHIPΔU-box inhibited the action of endogenous CHIP and blocked CFTR ubiquitination and degradation. CHIP is a co-chaperone that converts Hsc70 from a protein-folding machine into a degradation factor that functions in endoplasmic-reticulum quality control.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Riordan, J. R. et al. Science 245, 1066–1073 (1989); erratum ibid. 245, 1437 (1989).
Rich, D. P. et al. Nature 347, 358–363 (1990).
Cheng, S. H et al. Cell. 63, 827–834 (1990).
Ward, C. L. & Kopito, R. R. J. Biol. Chem. 269, 25710–25718 (1994).
Lukacs, G. L. et al. EMBO J. 13, 6076–6086 (1994).
Jensen, T. J. et al. Cell 83,129–135 (1995).
Ward, C. L., Omura, S. & Kopito, R. R. Cell. 83, 121–127 (1995).
Kartner, N. et al. Nature Genet. 1, 321–327 (1992).
Welsh, M. J. & Smith, A. E. Cell 73, 1251–1254 (1993).
Ballinger, C. A. et al. Mol. Cell. Biol. 19, 4535–4545 (1999).
Aravind, L. & Koonin, E.V. Curr. Biol. 10, R132–R134 (2000).
Pukatzki, S. et al. J. Biol. Chem. 273, 24131–24138 (1998).
Koegl, M. et al. Cell 96, 635–644 (1999).
Moyer, B.D. et al. J. Biol. Chem. 273, 21759–21768 (1998); erratum ibid. 273, 26256 (1998).
Ward, C. L. & Kopito, R.R. J. Cell Biol. 143, 1883–1898 (1998).
Wigley, W. C. et al. J. Cell Biol. 145, 481–490 (1999).
Garcia-Mata, R. et al. J. Cell Biol. 146, 1239–1254 (1999).
Strickland, E. et al. J. Cell Biol. 272, 25421–25424 (1997).
Meacham, G. C. et al. EMBO J. 18, 1492–1505 (1999).
Pind, S., Riordan, J. R. & Williams, D. B. J. Biol. Chem. 269, 12784–12788 (1994).
Loo, M. A. et al. EMBO J. 17, 6879–6887 (1998).
Takayama, S. et al. EMBO J. 16, 4887–4896 (1997).
Hohfeld, J. & Jentsch, S. EMBO J. 16, 6209–6216 (1997).
Hohfeld, J., Minami, Y. & Hartl, F. U. Cell. 83, 589–598 (1995).
Zhou, M. et al. J. Biol. Chem. 270, 25220–25224 (1995).
Fisher, E. A. et al. J. Biol. Chem. 272, 20427–20434 (1997).
Connell, P. et al. Nature Cell Biol. 3, 93–96
Johnson, B. D. et al. J. Biol. Chem. 273, 3679–3686 (1998).
Sommer, T. & Jentsch, S. Nature 365, 176–179 (1993).
Hiller, M. M. et al. Science 273, 1725–1728 (1996).
Lin, H & Wing, S. S. J. Biol. Chem. 274, 14685–146891 (1999).
Katsanis, N. & Fisher, E. M. Genomics 51, 128–1231 (1998).
Du, X. et al. J. Cell Biol. 141, 585–599 (1998).
Wickner, S., Maurizi, M. R. & Gottesman, S. Science 286, 1888–1893 (1999).
Kalin, N. et al. J. Clin. Invest. 103, 1379–1389 (1999).
Odorizzi, C. G. et al. J. Cell Biol. 126, 317–330 (1994).
Shamu, C. E. et al. J. Cell Biol. 147, 45–58 (1999).
Cyr, D. M., Lu, X. & Douglas, M. G. J. Biol. Chem. 267, 20927–20931 (1992).
Acknowledgements
We thank K. Kirk, D. Bewell and E. Stzul for providing antibodies; J. Collawn and H. Ginsberg for providing the transferrin receptor and apolipoprotein B48 expression plasmids; J. Höhfeld for helpful discussions and for providing Bag-1 and HIP expression plasmids; and B. Stanton for providing GFP–CFTR. D.M.C. is supported by grants from the NIH and the Cystic Fibrosis Foundation (CFF). C.P. is supported by the NIH. G.M. was supported by a predoctoral fellowship from the CFF.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Meacham, G., Patterson, C., Zhang, W. et al. The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. Nat Cell Biol 3, 100–105 (2001). https://doi.org/10.1038/35050509
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/35050509